Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03772652 · ClinicalTrials.gov registry record
Long-term Surgical Therapeutic Outcomes of Peri-Implantitis
A clinical trial, sponsored by University of Michigan.
- Terminated
- Registry status
- 38
- Enrollment target
NCT03772652: Clinical Trial study, sponsored by University of Michigan.
NCT03772652 is a clinical trial that was terminated before completion, run by University of Michigan. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03772652 was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- 38 participants
- Enrollment target
Study Summary
This study focuses on evaluating the success of different treatment methods for peri-implantitis (gum disease around implants) and to understand the factors that might affect the success of the treatment provided.
Primary Outcome
The implant has no further radiographic bone loss when compared to previous radiographs.
Interventions
- OTHER Observation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2018-12-04 |
| Est. Completion | 2020-02-13 |
Why NCT03772652 stopped before completion
NCT03772652 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 38 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Observation is the first listed.
NCT03772652 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03772652 about?
NCT03772652 is a clinical study titled "Long-term Surgical Therapeutic Outcomes of Peri-Implantitis". This study focuses on evaluating the success of different treatment methods for peri-implantitis (gum disease around implants) and to understand the factors that might affect the success of the treatment provided.
What is the current status of trial NCT03772652?
This trial is currently terminated. The enrollment target is 38 participants. The study started on 2018-12-04. Estimated completion is 2020-02-13.
What interventions are being tested in trial NCT03772652?
The interventions under investigation include: Observation (OTHER).
Who is sponsoring clinical trial NCT03772652?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI